ST. LOUIS (KMOX) – A new gene-altering treatment is now being offered locally for certain blood cancers.
It’s called CAR-T cell therapy. It harnesses a patient’s own immune system to fight cancer – in this case, advanced non-Hodgkin lymphoma in adults.
“This is really exciting because it’s going to give us a new option that is extremely effective,” says Washington University and Barnes-Jewish oncologist Dr. Armin Ghobadi. “This is a new platform that’s going to open up a new wave of treatments for all sorts of blood cancers, and hopefully even the solid tumors, lung cancers and other cancers. I believe it’s going to revolutionize the way we treat cancers in general.”
Siteman Cancer Center is one of only 16 cancer centers in the United States – and the only cancer center in Missouri – to offer this new type of cancer therapy for adults.